Talazoparib vs physicians choice for patients with mBRCA1 breast cancer

How can scalp-cooling reduce chemotherapy induced hair loss?

Acupuncture significantly reduces joint pain for breast cancer patients

Phase III trial data supports current standard 12-month adjuvant trastuzumab for HER2-positive breast cancer

Temporary ovarian suppression with hormone analogue may preserve fertility during breast cancer chemotherapy

Two years of extended anastrozole therapy as effective as five

Tandem duplicator phenotypes define 50% of triple negative breast cancers

Updated genomic screening tool for life-time breast cancer risk

Temporary ovarian suppression with hormone analogue may preserve fertility during breast cancer chemotherapy

Acupuncture significantly reduces joint pain for breast cancer patients

Immunotherapy shows early promise for patients with trastuzumab-resistant breast cancer

HR–positive advanced breast cancer: Ribociclib improved PFS for pre and perimenopausal women